A Prospective Study: the Value of Using iFlow and PBV in the Endovascular Treatment of Infrapopliteal Arterial Occlusive Diseases

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Aug 11, 2017

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients are diagnosed as lower limb atherosclerosis occlusion from June 2016 to June 2018 in our centre;
• • 2. All participating patients provided written informed consent and willing to participate;
• • 3. aged 40 years and more;
• • 4. the class of lower ischemia is upon 4;
• • 5. below-the-knee arteries stenosis or occlusion is indicated by duplex or computed tomographic angiography;
• • 6. there is no heavy stenosis in superficial femoral artery (stenosis\<30%), or short length lesion(length≤5cm, stenosis≥30%);
• • 7. infection or ulceration don't happen in the area of surgery;
• • 8. below the inguinal ligament arteries don't have the history of bypass or interventional surgery.
• Exclusion Criteria:
• • 1. disagree and refuse to the free therapy;
• • 2. lesion length of superior artery is more than 5cm;
• • 3. history of heart dysfunction: congestive heart failure,, myocardial infarction, severe arrhythmia;
• • 4. With severe metabolic disease, renal impairment(serum creatinine\>1.4mg/dL, glomerular filtration rate\<60) affect the excretion of contrast agents;
• • 5. have the diseases or agents which will reduce the viable of data;
• • 6. allergy to iodinated contrast medium.